Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

11.32
+0.28002.54%
Volume:27.98K
Turnover:317.66K
Market Cap:394.87M
PE:-11.57
High:11.55
Open:11.27
Low:11.15
Close:11.04
52wk High:16.76
52wk Low:9.85
Shares:34.88M
Float Shares:18.45M
Volume Ratio:0.41
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9783
EPS(LYR):-0.9800
ROE:-33.21%
ROA:-22.67%
PB:2.23
PE(LYR):-11.55

Loading ...

Jan 23, 2023

Major Issues Report

8-K - Current report
Dec 15, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Dec 12, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2022

Major Issues Report

8-K - Current report
Oct 18, 2022

Major Issues Report

8-K - Current report
Oct 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 23, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 16, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 07, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Major Issues Report

8-K - Current report
Sep 02, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 11, 2022

Correspondence

CORRESP [Cover] - Correspondence